β-Receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?
Open Access
- 28 February 2002
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (2) , 610-613
- https://doi.org/10.1016/s0003-4975(01)03418-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT TrialInternational Journal of Cardiology, 2001
- Pulmonary Risk Factors Compromising Postoperative Recovery After Surgical Repair for Congenital Heart DiseaseChest, 1999
- A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart diseaseEuropean Journal of Pharmacology, 1997
- Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing HeartCirculation, 1996
- Reduction in lymphoctye β-adreneraic receptor density in infants and children with heart failure secondary to congenital heart diseaseThe American Journal of Cardiology, 1996
- Regulation of Sympathetic Activity in Children with Various Congenital Heart DiseasesPediatric Research, 1995
- Beta adrenoceptor density in the donor heart: a guide to prognosis?Heart, 1995
- Distribution of Myocardial β‐Adrenoceptor Subtypes and Coupling to the Adenylate Cyclase in Children With Congenital Heart Disease and Implications for TreatmentThe Journal of Clinical Pharmacology, 1993
- Β-Adrenoceptor density on mononuclear leukocytes and right atrial myocardium in infants and children with congenital heart diseaseJournal of Molecular Medicine, 1991
- Myocardial β-adrenoceptor density and the distribution of 388-1388-1388-1388-2388-2388-2subpopulations in children with congenital heart diseaseEuropean Journal of Pediatrics, 1991